The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Hal B164, Baltimore, MD, 21287, USA.
Curr Oncol Rep. 2020 Apr 16;22(5):46. doi: 10.1007/s11912-020-00907-w.
We review advances in imaging of liver tumors, by particularly focusing on the utility of novel imaging in diagnosis and management of these lesions.
Contrast-enhanced CT and/or MRI are currently utilized for accurate diagnosis of liver tumors, but several ongoing studies are examining the use of other advanced techniques. Novel CT (i.e., dual-energy CT and perfusion CT), MRI (diffusion-weighted imaging, MR elastography, and T1 mapping), and image processing (texture analysis and artificial intelligence-based methods) techniques have emerged and can be used for precise characterization of liver tumors, quantification of treatment responses, and prediction of overall survival rate of patients. Recent advancements in imaging of liver tumors allowed for a precise assessment of tumor features. These evolving technologies can be utilized for applying individualized treatment based on the presence of specific imaging biomarkers.
我们综述了肝脏肿瘤影像学的进展,特别关注新型影像学在这些病变的诊断和管理中的应用。
目前,对比增强 CT 和/或 MRI 用于肝脏肿瘤的准确诊断,但多项正在进行的研究正在探讨其他先进技术的应用。新型 CT(即双能 CT 和灌注 CT)、MRI(弥散加权成像、MR 弹性成像和 T1 映射)和图像处理(纹理分析和基于人工智能的方法)技术已经出现,可用于肝脏肿瘤的精确特征描述、治疗反应的量化以及患者总生存率的预测。肝脏肿瘤影像学的最新进展使得对肿瘤特征的精确评估成为可能。这些不断发展的技术可用于根据特定的影像学生物标志物的存在来实施个体化治疗。